Immunoglobulin replacement therapy by self-infusion at home.

Twelve patients, ten with common variable hypogammaglobulinaemia and two with hypogammaglobulinaemia secondary to chronic lymphocytic leukaemia (CLL), have been taught to self-infuse their intravenous immunoglobulin replacement therapy. Follow-up of these patients has shown that regular self-infusio...

Full description

Bibliographic Details
Main Authors: Chapel, H, Brennan, V, Delson, E
Format: Journal article
Language:English
Published: 1988
_version_ 1797105006280704000
author Chapel, H
Brennan, V
Delson, E
author_facet Chapel, H
Brennan, V
Delson, E
author_sort Chapel, H
collection OXFORD
description Twelve patients, ten with common variable hypogammaglobulinaemia and two with hypogammaglobulinaemia secondary to chronic lymphocytic leukaemia (CLL), have been taught to self-infuse their intravenous immunoglobulin replacement therapy. Follow-up of these patients has shown that regular self-infusion at home is feasible and safe. There have been no anaphylactic or other serious reactions. Excellent patient compliance results from greater convenience and control over their own lives, in addition to time and money saved by the hospital.
first_indexed 2024-03-07T06:41:22Z
format Journal article
id oxford-uuid:f96595f7-7305-40e1-95d8-38590e2ca492
institution University of Oxford
language English
last_indexed 2024-03-07T06:41:22Z
publishDate 1988
record_format dspace
spelling oxford-uuid:f96595f7-7305-40e1-95d8-38590e2ca4922022-03-27T12:57:38ZImmunoglobulin replacement therapy by self-infusion at home.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f96595f7-7305-40e1-95d8-38590e2ca492EnglishSymplectic Elements at Oxford1988Chapel, HBrennan, VDelson, ETwelve patients, ten with common variable hypogammaglobulinaemia and two with hypogammaglobulinaemia secondary to chronic lymphocytic leukaemia (CLL), have been taught to self-infuse their intravenous immunoglobulin replacement therapy. Follow-up of these patients has shown that regular self-infusion at home is feasible and safe. There have been no anaphylactic or other serious reactions. Excellent patient compliance results from greater convenience and control over their own lives, in addition to time and money saved by the hospital.
spellingShingle Chapel, H
Brennan, V
Delson, E
Immunoglobulin replacement therapy by self-infusion at home.
title Immunoglobulin replacement therapy by self-infusion at home.
title_full Immunoglobulin replacement therapy by self-infusion at home.
title_fullStr Immunoglobulin replacement therapy by self-infusion at home.
title_full_unstemmed Immunoglobulin replacement therapy by self-infusion at home.
title_short Immunoglobulin replacement therapy by self-infusion at home.
title_sort immunoglobulin replacement therapy by self infusion at home
work_keys_str_mv AT chapelh immunoglobulinreplacementtherapybyselfinfusionathome
AT brennanv immunoglobulinreplacementtherapybyselfinfusionathome
AT delsone immunoglobulinreplacementtherapybyselfinfusionathome